Literature DB >> 11259842

Delivery systems for penetration enhancement of peptide and protein drugs: design considerations.

U B Kompella1, V H Lee.   

Abstract

This paper discusses the challenges to be met in designing delivery systems that maximize the absorption of peptide and protein drugs from the gastrointestinal and respiratory tracts. The ideal delivery system for either route of administration is one that will release its contents only at a favorable region of absorption, where the delivery system attaches by virtue of specific interaction with surface determinants unique to that region and where the delivery system travels at a rate independent of the transitory constraints inherent of the route of administration. Such a delivery system, which is as yet unavailable, will benefit not only peptide and protein drugs, but other poorly absorbed drugs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259842     DOI: 10.1016/s0169-409x(00)00137-x

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  23 in total

1.  Release of anti-inflammatory peptides from thermosensitive nanoparticles with degradable cross-links suppresses pro-inflammatory cytokine production.

Authors:  Scott Poh; Jenny B Lin; Alyssa Panitch
Journal:  Biomacromolecules       Date:  2015-03-11       Impact factor: 6.988

2.  Regional permeability of salmon calcitonin in isolated rat gastrointestinal tracts: transport mechanism using Caco-2 cell monolayer.

Authors:  Rakhi B Shah; Mansoor A Khan
Journal:  AAPS J       Date:  2004-10-21       Impact factor: 4.009

Review 3.  Past, present, and future technologies for oral delivery of therapeutic proteins.

Authors:  Rajesh Singh; Shailesh Singh; James W Lillard
Journal:  J Pharm Sci       Date:  2008-07       Impact factor: 3.534

4.  Delivery of anti-inflammatory peptides from hollow PEGylated poly(NIPAM) nanoparticles reduces inflammation in an ex vivo osteoarthritis model.

Authors:  James McMasters; Scott Poh; Jenny B Lin; Alyssa Panitch
Journal:  J Control Release       Date:  2017-05-08       Impact factor: 9.776

Review 5.  Long-term delivery of protein therapeutics.

Authors:  Ravi Vaishya; Varun Khurana; Sulabh Patel; Ashim K Mitra
Journal:  Expert Opin Drug Deliv       Date:  2014-09-24       Impact factor: 6.648

Review 6.  Current state and challenges in developing oral vaccines.

Authors:  Julia E Vela Ramirez; Lindsey A Sharpe; Nicholas A Peppas
Journal:  Adv Drug Deliv Rev       Date:  2017-04-22       Impact factor: 15.470

Review 7.  Approaches for enhancing oral bioavailability of peptides and proteins.

Authors:  Jwala Renukuntla; Aswani Dutt Vadlapudi; Ashaben Patel; Sai H S Boddu; Ashim K Mitra
Journal:  Int J Pharm       Date:  2013-02-18       Impact factor: 5.875

8.  Targeted delivery of YSA-functionalized and non-functionalized polymeric nanoparticles to injured pulmonary vasculature.

Authors:  Madhoosudan A Patil; Arun K Upadhyay; Laura Hernandez-Lagunas; Ryan Good; Todd C Carpenter; Carmen C Sucharov; Eva Nozik-Grayck; Uday B Kompella
Journal:  Artif Cells Nanomed Biotechnol       Date:  2018-11-19       Impact factor: 5.678

9.  Preparation of large porous deslorelin-PLGA microparticles with reduced residual solvent and cellular uptake using a supercritical carbon dioxide process.

Authors:  Kavitha Koushik; Uday B Kompella
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

10.  Oral insulin delivery by means of solid lipid nanoparticles.

Authors:  Bruno Sarmento; Susana Martins; Domingos Ferreira; Eliana B Souto
Journal:  Int J Nanomedicine       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.